-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the Zhitong Finance App, Hansite-B (03378.HK) announced that the innovative drug HX111 (HX111) for injection developed by the company has been approved by the China Drug Administration to conduct clinical trials in the People's Republic of China.

Zhitongcaijing·12/23/2025 13:17:10
Listen to the news
According to the Zhitong Finance App, Hansite-B (03378.HK) announced that the innovative drug HX111 (HX111) for injection developed by the company has been approved by the China Drug Administration to conduct clinical trials in the People's Republic of China.